| Ordering Recommendation: |
Order this test for PREGNANT FEMALE patients only. For males or non-pregnant females, refer to Alpha Fetoprotein, Serum (Tumor Marker) (0080428).
|
| Methodology: |
Quantitative Chemiluminescent Immunoassay
|
| Performed: |
Sun-Sat
|
| Reported: |
2-3 days
|
| Specimen Required: |
Patient Prep: Specimen must be drawn between 14 weeks, 0 days and 24 weeks, 6 days gestation.
Collect: Serum separator tube or plain red.
Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an ARUP Standard Transport Tube.
Storage/Transport Temperature: Refrigerated.
Remarks: The following information is required and must accompany the specimen in order for testing to be interpreted: patient's date of birth, current weight, due date, dating method (US, LMP), number of fetuses present, patient's race, if the patient requires insulin, if there is a known family history of neural tube defects, if the patient has had a previous pregnancy with a chromosome abnormality, if the patient is taking valproic acid or carbamazepine (Tegretol®), physician's name and phone number; and for in vitro fertilization pregnancies, the age of the egg donor.
Unacceptable Conditions: Plasma. Specimens exposed to repeated freeze/thaw cycles. Hemolyzed specimens.
Stability (collection to initiation of testing): After separation from cells: Ambient: 24 hours; Refrigerated: 1 week; Frozen: 1 year
|
|
|
![[ image for: Patient History For Maternal Serum Testing]](icon_17.jpg){kind=icon}